(Corrects expected approval timing to July)
BERLIN, April 28 (Reuters) - BioNTech expects that the COVID-19 vaccine it is making with Pfizer will win approval from the Chinese health authorities “by July at the latest”, Chief Executive Ugur Sahin said on Wednesday.
This would mean that it would be possible to distribute the vaccine in China from July, the founder of the biotech startup told an online briefing with the German foreign correspondents’ association.
“I am optimistic that we can help the people of China,” said Sahin, adding that local partner Shanghai Fosun Pharmaceutical Group Co Ltd was “a great company”. (Reporting by Douglas Busvine, editing by Kirsti Knolle)